/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Medivation Inc.\n \n\n\n\n\n
Nov 21 4:53 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 11, 2009 8:01 AM EST
\n\n \n Medivation to Present at Lazard Capital Markets Sixth Annual Healthcare Conference - PR Newswire\n \n \n
\n\n Nov 04, 2009 4:01 PM EST
\n\n \n Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update - PR Newswire\n \n \n
\n\n Nov 03, 2009 8:00 AM EST
\n\n \n Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer's Disease - Business Wire\n \n \n
\n\n Oct 28, 2009 8:02 AM EDT
\n\n \n Medivation Announces Third Quarter 2009 Financial Results Teleconference and Webcast on November 4, 2009 - PR Newswire\n \n \n
\n\n Oct 27, 2009 7:30 AM EDT
\n\n \n Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer - PR Newswire\n \n \n
\n\n Oct 26, 2009 5:00 PM EDT
\n\n \n Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for MDV3100 - PR Newswire\n \n \n
\n\n Oct 23, 2009 8:00 AM EDT
\n\n \n Medivation Names Hank Mansbach, M.D., Vice President of Medical Affairs - PR Newswire\n \n \n
\n
\n\n");